Great American Products warning letter
This article was originally published in The Tan Sheet
Executive Summary
Twenty dietary supplements marketed by Great American Products may be unapproved new drugs because of labeling claims that violate the FD&C Act, FDA says in an April 18 warning letter. Statements cited by the agency that appear in internet advertising and the company catalog claim Prostate Assist is "effective in helping to reduce the risk of prostate cancer," Cholesterol Assist "has the ingredients that have been known to lower cholesterol levels" and Ultimate Glucose Advantage is "designed to effectively help reduce your glucose levels - a crucial function for those people with diabetes." Claims for the firm's Ultimate HGH product were referred to FTC by the Electronic Retailing Self-Regulation Program in September (1"The Tan Sheet" Sept. 20, 2004, In Brief)...
You may also be interested in...
ERSP referral
Claims for Great American Products' Ultimate HGH were referred to the Federal Trade Commission after the firm said it would not participate for "confidential reasons," ERSP announces Sept. 13. Claims from a 30-minute infomercial that initiated the case include statements that the product could "reverse the aging process," remove wrinkles and improve vision...
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.